Polycystic Ovary Syndrome - Improving Outcomes

NCT01504321 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: Moxonidine
DRUG: Placebo

Sponsor

Baker Heart and Diabetes Institute